Key result
Guinea pig models show value for viral immunity but require validated quantitative biomarkers.
The guinea pig serves as a valuable model for viral infectious diseases, though further development of validated biomarkers is needed.
Answers are grounded in this paper and cite their sources.
Guinea pig models merit expanded virology research use; leaves open clinical translation until quantitative biomarkers are validated.
The guinea pig model of disease has been considered synonymous with the experimental laboratory animal since the nineteenth century. Recently we have reviewed the use of this species in models of bacterial infectious disease. The present review extends to viral diseases for which the guinea pig is less frequently considered the relevant animal model. The use of the guinea pig as a laboratory animal, aspects of immunology, viral pathogens and host-pathogen models are discussed. As a small and relatively inexpensive model for infection and immunity the guinea pig has a significant future but there are substantial requirements for development of validated quantitative analytical methods for immunological and disease biomarkers if it is to reach its potential.
No takes yet. Share an insight, caveat, or question.
Anthony J. Hickey (2011) conducted a review in Viral infectious diseases. Guinea pig model was evaluated. The guinea pig serves as a valuable small animal model for viral infections and immunity, though it requires further development of validated quantitative biomarkers to reach its full potential.
Synapse has enriched 10 related papers. Consider them for comparative context: